Should I Buy HNNA? HNNA 2026 Analysis

Should You Buy Hennessy Advisors Inc (HNNA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

10.350

1 Day change

-0.29%

52 Week Range

13.190

Analysis Updated At

2026/01/29

HNNA is not a good buy right now for a beginner long-term investor who is impatient. The setup is mostly neutral (no proprietary buy signals, no news catalysts, neutral hedge/insider activity), and fundamentals show slight revenue contraction. I would hold off buying now and only consider it if it breaks and holds above the 10.77 resistance with improving momentum or if revenue growth re-accelerates.

Technical Analysis

Price closed at 10.37 (-1.70% vs prior close 10.38), sitting just above the pivot (10.344) and well above first support (S1 9.917). Momentum is mildly positive but not strengthening: MACD histogram is above zero (0.0618) but positively contracting (bullish momentum fading). RSI(6) at 52.5 is neutral. Moving averages are converging, suggesting consolidation rather than a clear uptrend. Near-term levels: support 9.92 then 9.65; resistance 10.77 then 11.04. Pattern-based stats provided imply only a ~50% chance of modest gains (+1.59% 1-day, +2.88% 1-week, +8.96% 1-month), which is not strong enough to justify an impatient entry. Intellectia Proprietary Trading Signals: - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Positive Catalysts

- Profitability trend improved despite revenue softness: 2025/Q4 net income +4.04% YoY and EPS +3.33% YoY.
- Technicals are not bearish: RSI neutral and MACD still above zero.
- No negative news flow in the last week (no fresh headline risk in the dataset).

Neutral/Negative Catalysts

- Revenue declined in 2025/Q4 (-2.46% YoY), which limits confidence in sustained long-term compounding without a re-acceleration.
- No clear institutional/insider conviction: hedge funds neutral (last quarter) and insiders neutral (last month).
- No event-driven catalysts ("No news in recent week") and no proprietary buy signals today, reducing the odds of an immediate move (important for an impatient buyer).
- Momentum is not building: MACD is contracting and price is consolidating around the pivot rather than breaking out.

Financial Performance

Latest quarter: 2025/Q4. Revenue was 7.459M (-2.46% YoY), while net income rose to 2.422M (+4.04% YoY) and EPS increased to 0.31 (+3.33% YoY). Overall: earnings improved, but top-line growth is negative, suggesting cost/expense improvements rather than business expansion. (Gross margin data provided is not meaningful here: shown as 0 with 0% change.)

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so no recent trend can be confirmed. From a 'Wall Street pros/cons' standpoint based on the dataset: Pros—improving EPS/net income and neutral (not overbought) technicals. Cons—declining revenue, no catalysts/news, and no actionable trading signals. Politicians/congress: no recent congress trading data available (no indication of influential buying/selling in the last 90 days).

Analyst Rating

Wall Street analysts forecast HNNA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HNNA is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 10.380

Low

Averages

High